# A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)

> **NCT02486432** · PHASE1 · COMPLETED · sponsor: **NeuroDerm Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Levodopa/Carbidopa (Sinemet)

## Key facts

- **NCT ID:** NCT02486432
- **Lead sponsor:** NeuroDerm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02486432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02486432, "A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02486432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*